Cigna’s Recovery Potential Despite Setbacks: A Buy Rating Justified by Strategic Positioning and Growth Prospects
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CI stock, giving a Buy rating yesterday.Invest with Confidence: ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Vertex Pharmaceuticals (VRTX) and Arcus Biosciences (RCUS)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cigna (CI – Research Report), Vertex Pharmaceuticals (VRTX – ...
French Inflation Stays Cool in January After ECB Cut Rates Again
French inflation was stable at the beginning of the year, figures showed Friday, a day after the European Central Bank again ...